EP4 prostanoid receptor agonists (Roche)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameEP4 prostanoid receptor agonists (Roche)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstanoid EP4 receptor agonists
TargetsProstanoid EP4 receptor
Therapy Area/IndicationsOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRoche Palo Alto Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRoche Palo Alto Llc
Active IndicationsN/A
Inactive IndicationsOsteoporosis

Other Information

ATC CodeN/A
Related LinksN/A